Business ❯Finance

Pharmaceuticals

Drug Sales Drug Development Company Performance Eli Lilly Earnings Reports Vaccine Development Vaccines Pfizer Market Performance COVID-19 Treatments Licensing Agreements Axsome Therapeutics Moderna Earnings Pharmaceutical Companies Healthcare Product Performance Product Launches Regulatory Approvals R&D Expenses AstraZeneca Merck Medications Bristol Myers Squibb Production Expansion Drug Launches Revenue Drug Companies Corporate Earnings Drug Approvals Weight Loss Manufacturing Opioid Crisis Lupin Drug Approval Biotechnology Regulatory Compliance Drug Funding Health Sales Growth COVID-19 Vaccines Vaccine Sales Weight-loss Drugs Weight-Loss Drugs Corporate Performance

Indivior to Abandon London Listing to Focus Solely on Nasdaq

Cutting the secondary London listing will reduce administrative costs by aligning share trading with where over 80% of its revenue is generated

Emcure Pharmaceuticals Reports 64% Profit Surge, Shares Hit Upper Circuit

Sun Pharma Shares Drop 5% Following Mixed Q4 FY25 Results

Novo Nordisk Revises 2025 Outlook as FDA Crackdown and Competition Reshape Wegovy Market

Moderna Reports Narrower Q1 Loss, Updates Cost-Cutting and Regulatory Timelines

T-Mobile's Q1 Earnings Beat Overshadowed by Subscriber Growth Miss

AbbVie Raises 2025 Profit Forecast Following Strong Q1 Growth in Immunology Drugs

Bristol Myers Squibb Raises 2025 Forecast After Surpassing Q1 Expectations

Eli Lilly Reports Mixed Q4 Results as Key Drug Sales Fall Short of Expectations

Merck Cuts 2025 Revenue Forecast After Halting Gardasil Shipments to China

Pfizer Exceeds Q4 Earnings Expectations with Strong Covid Product Sales and Cost Cuts

AbbVie Reports Strong Sales Growth for Skyrizi and Rinvoq, Boosts 2027 Revenue Outlook

Eli Lilly Lowers 2024 Revenue Forecast Due to Slower Weight-Loss Drug Growth

PTC Therapeutics and Novartis Sign $3 Billion Deal for Huntington's Disease Drug Development

Bristol Myers Squibb Surpasses Q3 Expectations, Raises 2024 Outlook

Pfizer's Strong Q3 Earnings Challenge Activist Investor's Push for Change

Eli Lilly's Weight-Loss Drugs Drive Record Q2 Revenue Surge

Eli Lilly's Q2 Earnings Surge on High Demand for Weight-Loss Drugs

Pfizer and Merck Diverge in Q2 Performance Amid Revised Forecasts

Bristol Myers Squibb Surges on Strong Q2 Performance and Raised Guidance